Modeling human carcinomas: Physiologically relevant 3D models to improve anti-cancer drug development
Anti-cancer drug development is inefficient, mostly due to lack of efficacy in human patients. The high fail rate is partly due to the lack of predictive models or the inadequate use of existing preclinical test systems. However, progress has been made and preclinical models were improved or newly d...
Saved in:
Published in | Advanced drug delivery reviews Vol. 79-80; pp. 50 - 67 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier B.V
15.12.2014
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!